Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
TARS
#1395
Tarsus Pharmaceuticals, Inc. Common Stock
75.520
0
+1.46%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.46%
Variazione Mensile
+11.06%
Variazione di 6 mesi
+14.32%
Variazione Annuale
+14.32%
Chiusura Precedente
74.435
0
Open
75.520
0
Bid
Ask
Low
75.520
0
High
75.520
0
Volume
74
Mercati
Mercato Azionario Statunitense
Salute
TARS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
0
0
0
0
0
0
—
Dividend yield %
0
0
0
0
0
0
—
Payout ratio %
—
0
0
0
0
0
—
Notizie
Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens
Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders
AMD, IBM among market cap stock movers on Tuesday
Gli EPS di Tarsus hanno mancato le aspettative per 0,12$, il fatturato supera le previsioni
Tarsus earnings missed by $0.12, revenue topped estimates
Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-02-23
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth
Tarsus affronta il test degli utili mentre le perdite si riducono e i ricavi aumentano
Tarsus faces earnings test as losses narrow, revenue surges